Data Collection Name

ID
Brats Subject ID
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Sex at birth
Race
Ethnicity
Primary Diagnosis
Days from Acquisition to Date of initial surgery, treatm
Days from Acquisition to Date of last surgery prior to sc
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
IDH
1p19q
ATRX
Days from Acquisition to Date of last follow-up
Days from Acquisition to Date of death
Overall survival
Progression free survival
Surgery
Number of surgeries
Surgery extend
Radiation
Number of radiation courses
Days from Acquisition to Date of first radiation
Days from Acquisition to Date of last radiation prior to
1st Chemo type
Days from Acquisition to Date of 1st chemo start
Avastin® (bevacizumab)
Days from Acquisition to Date of last Avastin treatment
Other treatment prior to scan
Days from Acquisition to Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Brats Subject ID
Site
Site Subject ID
Timepoint
Acquisition Date
Magnetic Field Strength
Manufacturer
Manufacturer's Model Name
Patient's Age
Patient's Sex
Glioma Type
Date of initial surgery, treatment or diagnosis
Days from initial surgery, treatment or diagnosis to scan
WHO 2021 Diagnosis
Non WHO 2021 Diagnosis
Grade
MGMT
MGMT methylation index
IDH
1p19q
ATRX
Survival time from initial diagnosis to last follow-up
Surgery
Number of surgeries
Date of first surgery
Date of last surgery
Radiation
Number of radiation courses
Date of first radiation
Date of last radiation
1st Chemo type
Date of 1st chemo start
Avastin® (bevacizumab)
Date of last Avastin treatment
Other treatment
Other treatment dates
Data Descriptor /Metadata Name
TCIA ID
ID used in the BraTS 2024 challenge
Date of the acquisition
Magnetic field strength of the scanner
Manufacturer of the scanner
Model Name of the scanner
At time of scan (in years)
M/F
American Indian or Alaska Native/Asian/Native Hawaiian or Pacific Islander/Black or African American/White/Unkno
Hispanic or Latino/Not Hispanic or Latino/Unknown / Not Reported
Glioblastoma; Oligoastrocytoma; Astrocytoma, IDH-Mutant, Grade 4; Anaplastic Astrocytoma
Either date of surgery, or other initial treatment if patient did not undergo surgery at the time of diagnosis, or date o
Date of last surgery prior to scan if different from the date of initial surgery
Diagnostic classification according to WHO 2021 criteria
Diagnostic classification prior to WHO 2021
Grade according to criteria at the time of diagnostic
MGMT methylation, either methylated or unmethylated
IDH mutation status, either mutated or wild type
1p19q codeletion status, either codeleted or intact = not 1p19q codeleted
ATRX status. Loss = indication of mutation, intact = ATRX retained, no indication of mutation
Date of last follow up from the clinical record
Date of death
Days between initial surgery and death
Days between initial surgery and first sign of progression
Yes/No
Number of surgeries
GTR/STR/Biopsy
Yes/No
Number of radiation courses
Date of first radiation
Date of last radiation prior to scan
Type of first chemotherapy agent
Date of first chemotherapy treatment start
Yes/No
Date of last Avastin treatment prior to scan
Yes/No
Date of other treatment if known
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
nosis to scan
can American/White/Unknown / Not Reported

e time of diagnosis, or date of diagnosis if patient did not recive any treatment
ID BraTS ID Magnetic FielManufacturer
UCSD-PTGBM-0001_01 BraTS-GLI-02250-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0002_01 BraTS-GLI-02251-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0003_01 BraTS-GLI-02252-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0004_01 BraTS-GLI-02253-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0004_02 BraTS-GLI-02253-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0005_01 BraTS-GLI-02254-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0005_02 BraTS-GLI-02254-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0006_01 BraTS-GLI-02255-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0007_01 BraTS-GLI-02256-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0007_02 BraTS-GLI-02256-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0008_01 BraTS-GLI-02257-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0008_02 BraTS-GLI-02257-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0008_03 BraTS-GLI-02257-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0009_01 BraTS-GLI-02258-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0010_01 BraTS-GLI-02259-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0011_01 BraTS-GLI-02260-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0012_01 BraTS-GLI-02261-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0013_01 BraTS-GLI-02262-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0014_01 BraTS-GLI-02263-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0015_01 BraTS-GLI-02264-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0016_01 BraTS-GLI-02265-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0017_01 BraTS-GLI-02267-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0017_02 BraTS-GLI-02267-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0018_01 BraTS-GLI-02268-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0018_02 BraTS-GLI-02268-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0019_01 BraTS-GLI-02269-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0019_02 BraTS-GLI-02269-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0020_01 BraTS-GLI-02270-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0021_01 BraTS-GLI-02271-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0022_01 BraTS-GLI-02272-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0022_02 BraTS-GLI-02272-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0023_01 BraTS-GLI-02273-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0024_01 BraTS-GLI-02274-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0025_01 BraTS-GLI-02275-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0025_02 BraTS-GLI-02275-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0025_03 BraTS-GLI-02275-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0026_01 BraTS-GLI-02276-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0027_01 BraTS-GLI-02277-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0028_01 BraTS-GLI-02279-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0029_01 BraTS-GLI-02280-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0030_01 BraTS-GLI-02282-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0031_01 BraTS-GLI-02284-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0032_01 BraTS-GLI-02285-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0032_02 BraTS-GLI-02285-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0032_03 BraTS-GLI-02285-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0032_04 BraTS-GLI-02285-103 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0033_01 BraTS-GLI-02286-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0033_02 BraTS-GLI-02286-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0033_03 BraTS-GLI-02286-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0034_01 BraTS-GLI-02287-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0034_02 BraTS-GLI-02287-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0035_01 BraTS-GLI-02288-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0036_01 BraTS-GLI-02289-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0036_02 BraTS-GLI-02289-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0038_03 BraTS-GLI-02289-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0037_01 BraTS-GLI-02290-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0037_02 BraTS-GLI-02290-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0037_03 BraTS-GLI-02290-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0038_01 BraTS-GLI-02291-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0038_02 BraTS-GLI-02291-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0039_01 BraTS-GLI-02292-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0040_01 BraTS-GLI-02293-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0041_01 BraTS-GLI-02294-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0042_01 BraTS-GLI-02295-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0042_02 BraTS-GLI-02295-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0042_03 BraTS-GLI-02295-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0043_01 BraTS-GLI-02296-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0044_01 BraTS-GLI-02297-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0045_01 BraTS-GLI-02298-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0046_01 BraTS-GLI-02299-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0047_01 BraTS-GLI-02300-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0047_02 BraTS-GLI-02300-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0048_01 BraTS-GLI-02301-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0048_02 BraTS-GLI-02301-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0048_03 BraTS-GLI-02301-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0049_01 BraTS-GLI-02302-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0050_01 BraTS-GLI-02303-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0050_02 BraTS-GLI-02303-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0050_03 BraTS-GLI-02303-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0050_04 BraTS-GLI-02303-103 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0051_01 BraTS-GLI-02304-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0052_01 BraTS-GLI-02305-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0052_02 BraTS-GLI-02305-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0052_03 BraTS-GLI-02305-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0053_01 BraTS-GLI-02307-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0053_02 BraTS-GLI-02307-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0053_03 BraTS-GLI-02307-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0054_01 BraTS-GLI-02308-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0055_01 BraTS-GLI-02309-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0056_01 BraTS-GLI-02310-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0057_01 BraTS-GLI-02312-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0058_01 BraTS-GLI-02313-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0059_01 BraTS-GLI-02314-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0060_01 BraTS-GLI-02315-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0061_01 BraTS-GLI-02316-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0062_01 BraTS-GLI-02317-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0063_01 BraTS-GLI-02318-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0064_01 BraTS-GLI-02319-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0065_01 BraTS-GLI-02320-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0066_01 BraTS-GLI-02321-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0066_02 BraTS-GLI-02321-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0067_01 BraTS-GLI-02322-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0068_01 BraTS-GLI-02323-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0069_01 BraTS-GLI-02324-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0070_01 BraTS-GLI-02325-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0071_01 BraTS-GLI-02326-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0072_01 BraTS-GLI-02327-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0073_01 BraTS-GLI-02328-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0073_02 BraTS-GLI-02328-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0074_01 BraTS-GLI-02329-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0075_01 BraTS-GLI-02330-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0076_01 BraTS-GLI-02331-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0077_01 BraTS-GLI-02332-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0078_01 BraTS-GLI-02333-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0079_01 BraTS-GLI-02334-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0080_01 BraTS-GLI-02335-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0081_01 BraTS-GLI-02336-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0082_01 BraTS-GLI-02337-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0083_01 BraTS-GLI-02338-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0084_01 BraTS-GLI-02339-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0085_01 BraTS-GLI-02340-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0086_01 BraTS-GLI-02341-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0087_01 BraTS-GLI-02342-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0088_01 BraTS-GLI-02343-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0089_01 BraTS-GLI-02344-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0090_01 BraTS-GLI-02345-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0091_01 BraTS-GLI-02346-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0092_01 BraTS-GLI-02347-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0093_01 BraTS-GLI-02348-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0094_01 BraTS-GLI-02349-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0095_01 BraTS-GLI-02350-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0096_01 BraTS-GLI-02351-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0097_01 BraTS-GLI-02352-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0098_01 BraTS-GLI-02353-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0099_01 BraTS-GLI-02354-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0100_01 BraTS-GLI-02355-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0101_01 BraTS-GLI-02356-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0101_02 BraTS-GLI-02356-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0102_01 BraTS-GLI-02357-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0103_01 BraTS-GLI-02358-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0103_02 BraTS-GLI-02358-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0104_01 BraTS-GLI-02359-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0105_01 BraTS-GLI-02360-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0106_01 BraTS-GLI-02361-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0107_01 BraTS-GLI-02362-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0108_01 BraTS-GLI-02363-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0109_01 BraTS-GLI-02364-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0109_02 BraTS-GLI-02364-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0110_01 BraTS-GLI-02365-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0111_01 BraTS-GLI-02366-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0112_01 BraTS-GLI-02367-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0113_01 BraTS-GLI-02368-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0114_01 BraTS-GLI-02369-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0115_01 BraTS-GLI-02370-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0116_01 BraTS-GLI-02371-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0116_02 BraTS-GLI-02371-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0117_01 BraTS-GLI-02372-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0118_01 BraTS-GLI-02373-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0119_01 BraTS-GLI-02374-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0119_02 BraTS-GLI-02374-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0120_01 BraTS-GLI-02375-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0120_02 BraTS-GLI-02375-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0121_01 BraTS-GLI-02376-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0121_02 BraTS-GLI-02376-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0122_01 BraTS-GLI-02377-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0123_01 BraTS-GLI-02378-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0123_02 BraTS-GLI-02378-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0123_03 BraTS-GLI-02378-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0124_01 BraTS-GLI-02379-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0124_02 BraTS-GLI-02379-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0125_01 BraTS-GLI-02380-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0126_01 BraTS-GLI-02381-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0127_01 BraTS-GLI-02382-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0128_01 BraTS-GLI-02383-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0129_01 BraTS-GLI-02384-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0130_01 BraTS-GLI-02385-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0131_01 BraTS-GLI-02386-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0132_01 BraTS-GLI-02387-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0133_01 BraTS-GLI-02388-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0133_02 BraTS-GLI-02388-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0134_01 BraTS-GLI-02389-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0135_01 BraTS-GLI-02390-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0135_02 BraTS-GLI-02390-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0135_03 BraTS-GLI-02390-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0136_01 BraTS-GLI-02391-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0137_01 BraTS-GLI-02392-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0137_02 BraTS-GLI-02392-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0138_01 BraTS-GLI-02393-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0139_01 BraTS-GLI-02394-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0140_01 BraTS-GLI-02395-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0140_02 BraTS-GLI-02395-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0141_01 BraTS-GLI-02396-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0142_01 BraTS-GLI-02397-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0143_01 BraTS-GLI-02398-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0144_01 BraTS-GLI-02399-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0144_02 BraTS-GLI-02399-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0145_01 BraTS-GLI-02400-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0145_02 BraTS-GLI-02400-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0146_01 BraTS-GLI-02401-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0147_01 BraTS-GLI-02402-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0147_02 BraTS-GLI-02402-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0148_01 BraTS-GLI-02403-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0149_01 BraTS-GLI-02404-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0149_02 BraTS-GLI-02404-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0150_01 BraTS-GLI-02405-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0150_02 BraTS-GLI-02405-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0151_01 BraTS-GLI-02406-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0152_01 BraTS-GLI-02407-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0153_01 BraTS-GLI-02408-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0154_01 BraTS-GLI-02409-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0155_01 BraTS-GLI-02410-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0155_02 BraTS-GLI-02410-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0156_01 BraTS-GLI-02411-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0157_01 BraTS-GLI-02412-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0158_01 BraTS-GLI-02413-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0159_01 BraTS-GLI-02414-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0160_01 BraTS-GLI-02415-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0161_01 BraTS-GLI-02416-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0162_01 BraTS-GLI-02417-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0162_02 BraTS-GLI-02417-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0163_01 BraTS-GLI-02418-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0163_02 BraTS-GLI-02418-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0163_03 BraTS-GLI-02418-102 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0164_01 BraTS-GLI-02419-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0165_01 BraTS-GLI-02420-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0166_01 BraTS-GLI-02421-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0167_01 BraTS-GLI-02422-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0167_02 BraTS-GLI-02422-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0168_01 BraTS-GLI-02423-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0169_01 BraTS-GLI-02424-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0170_01 BraTS-GLI-02425-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0171_01 BraTS-GLI-02426-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0172_01 BraTS-GLI-02427-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0172_02 BraTS-GLI-02427-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0173_01 BraTS-GLI-02428-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0174_01 BraTS-GLI-02429-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0174_02 BraTS-GLI-02429-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0175_01 BraTS-GLI-02430-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0176_01 BraTS-GLI-02431-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0176_02 BraTS-GLI-02431-101 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0177_01 BraTS-GLI-02432-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0178_01 BraTS-GLI-02433-100 3 GE MEDICAL SYSTEMS
UCSD-PTGBM-0178_02 BraTS-GLI-02433-101 3 GE MEDICAL SYSTEMS
Manufacturer's Model Patient's AgeSex at birth Race
DISCOVERY MR750 20 Female White
DISCOVERY MR750 59 Female White
DISCOVERY MR750 54 Female White
DISCOVERY MR750 45 Male White
DISCOVERY MR750 45 Male White
DISCOVERY MR750 55 Male White
DISCOVERY MR750 55 Male White
DISCOVERY MR750 54 Male White
DISCOVERY MR750 61 Male White
DISCOVERY MR750 61 Male White
DISCOVERY MR750 60 Male White
DISCOVERY MR750 60 Male White
DISCOVERY MR750 60 Male White
DISCOVERY MR750 61 Male White
DISCOVERY MR750 73 Male Asian
DISCOVERY MR750 54 Male White
DISCOVERY MR750 55 Male White
DISCOVERY MR750 60 Male White
DISCOVERY MR750 50 Male Unknown
DISCOVERY MR750 45 Female White
DISCOVERY MR750 29 Male Black or African American
Signa HDxt 27 Female White
Signa HDxt 27 Female White
Signa HDxt 26 Male White
Signa HDxt 26 Male White
DISCOVERY MR750 54 Male White
DISCOVERY MR750 54 Male White
DISCOVERY MR750 53 Male White
DISCOVERY MR750 60 Male Unknown
DISCOVERY MR750 70 Male White
DISCOVERY MR750 70 Male White
DISCOVERY MR750 35 Male Asian
DISCOVERY MR750 66 Male Unknown
DISCOVERY MR750 47 Male White
DISCOVERY MR750 47 Male White
DISCOVERY MR750 47 Male White
DISCOVERY MR750 50 Male White
DISCOVERY MR750 74 Male White
DISCOVERY MR750 66 Female Unknown
DISCOVERY MR750 65 Male White
DISCOVERY MR750 73 Female Unknown
DISCOVERY MR750 63 Male White
DISCOVERY MR750 72 Male White
DISCOVERY MR750 72 Male White
DISCOVERY MR750 72 Male White
DISCOVERY MR750 72 Male White
DISCOVERY MR750 69 Male White
DISCOVERY MR750 69 Male White
DISCOVERY MR750 69 Male White
DISCOVERY MR750 59 Male White
DISCOVERY MR750 59 Male White
DISCOVERY MR750 36 Female Asian
DISCOVERY MR750 66 Male White
DISCOVERY MR750 66 Male White
DISCOVERY MR750 66 Male White
Signa HDxt 44 Male White
Signa HDxt 44 Male White
Signa HDxt 44 Male White
Signa HDxt 56 Male Unknown
Signa HDxt 56 Male Unknown
Signa HDxt 64 Male White
Signa HDxt 62 Male Asian
Signa HDxt 56 Female Native Hawaiian or Other Pacific
DISCOVERY MR750 29 Female White
DISCOVERY MR750 29 Female White
DISCOVERY MR750 29 Female White
DISCOVERY MR750 45 Female White
DISCOVERY MR750 54 Female White
DISCOVERY MR750 62 Male White
DISCOVERY MR750 45 Male White
Signa HDxt 58 Male White
DISCOVERY MR750 58 Male White
DISCOVERY MR750 60 Male White
DISCOVERY MR750 60 Male White
DISCOVERY MR750 60 Male White
DISCOVERY MR750 53 Male White
DISCOVERY MR750 53 Male White
DISCOVERY MR750 53 Male White
DISCOVERY MR750 53 Male White
DISCOVERY MR750 53 Male White
DISCOVERY MR750 70 Male White
DISCOVERY MR750 47 Male Unknown
DISCOVERY MR750 47 Male Unknown
DISCOVERY MR750 47 Male Unknown
Signa HDxt 39 Male Unknown
Signa HDxt 39 Male Unknown
Signa HDxt 39 Male Unknown
DISCOVERY MR750 63 Male White
DISCOVERY MR750 81 Female White
DISCOVERY MR750 29 Male White
DISCOVERY MR750 49 Male White
DISCOVERY MR750 53 Male White
DISCOVERY MR750 56 Female White
DISCOVERY MR750 54 Male White
DISCOVERY MR750 74 Male White
DISCOVERY MR750 67 Male White
DISCOVERY MR750 47 Male White
DISCOVERY MR750 76 Male Unknown
DISCOVERY MR750 33 Female White
DISCOVERY MR750 62 Male White
DISCOVERY MR750 62 Male White
DISCOVERY MR750 60 Female White
DISCOVERY MR750 53 Female White
DISCOVERY MR750 45 Male White
DISCOVERY MR750 61 Male Unknown
DISCOVERY MR750 70 Male White
DISCOVERY MR750 56 Female White
DISCOVERY MR750 66 Female White
DISCOVERY MR750 66 Female White
DISCOVERY MR750 36 Female White
DISCOVERY MR750 39 Male Unknown
DISCOVERY MR750 29 Female White
DISCOVERY MR750 47 Male White
DISCOVERY MR750 64 Male White
DISCOVERY MR750 54 Female White
DISCOVERY MR750 68 Male White
DISCOVERY MR750 66 Male White
DISCOVERY MR750 43 Male White
DISCOVERY MR750 59 Female White
DISCOVERY MR750 62 Male White
DISCOVERY MR750 49 Male White
DISCOVERY MR750 27 Male White
DISCOVERY MR750 62 Female White
DISCOVERY MR750 81 Female White
DISCOVERY MR750 73 Male White
DISCOVERY MR750 52 Male White
DISCOVERY MR750 56 Female White
DISCOVERY MR750 53 Female Unknown
DISCOVERY MR750 56 Male Unknown
DISCOVERY MR750 52 Male Unknown
DISCOVERY MR750 58 Male Asian
DISCOVERY MR750 64 Male Asian
DISCOVERY MR750 71 Male White
DISCOVERY MR750 76 Male White
Native Hawaiian or Other
DISCOVERY MR750 67 Male Pacific Islander/ Asian
DISCOVERY MR750 61 Male White
DISCOVERY MR750 88 Male Black or African American
DISCOVERY MR750 88 Male Black or African American
DISCOVERY MR750 79 Male White
DISCOVERY MR750 77 Male White
DISCOVERY MR750 77 Male White
DISCOVERY MR750 55 Male White
DISCOVERY MR750 74 Female Unknown
DISCOVERY MR750 56 Male Unknown
DISCOVERY MR750 76 Female White
DISCOVERY MR750 41 Female White
DISCOVERY MR750 62 Female White
DISCOVERY MR750 62 Female Unknown
DISCOVERY MR750 57 Female Unknown
DISCOVERY MR750 57 Female Unknown
DISCOVERY MR750 61 Male White
DISCOVERY MR750 70 Male White
DISCOVERY MR750 61 Male White
DISCOVERY MR750 51 Female White
DISCOVERY MR750 20 Female White
DISCOVERY MR750 20 Female White
Signa HDxt 52 Male White
Signa HDxt 41 Male White
Signa HDxt 48 Male White
Signa HDxt 48 Male White
Signa HDxt 57 Female Unknown
Signa HDxt 57 Female Unknown
Signa HDxt 59 Female White
Signa HDxt 59 Female White
Signa HDxt 52 Female Unknown
Signa HDxt 52 Female Unknown
Signa HDxt 52 Female Unknown
Signa HDxt 52 Female Unknown
Signa HDxt 65 Female Unknown
Signa HDxt 65 Female White
Signa HDxt 52 Female White
Signa HDxt 60 Female White
Signa HDxt 58 Female White
Signa HDxt 81 Female White
Signa HDxt 50 Female White
Signa HDxt 50 Female White
Signa HDxt 38 Male Native Hawaiian or Other Pacific
Signa HDxt 69 Male White
Signa HDxt 62 Male White
Signa HDxt 62 Male White
Signa HDxt 45 Male White
Signa HDxt 39 Male White
Signa HDxt 39 Male White
Signa HDxt 39 Male White
Signa HDxt 49 Male White
Signa HDxt 62 Male White
Signa HDxt 62 Male Unknown
Signa HDxt 68 Female White
Signa HDxt 69 Female White
Signa HDxt 22 Female White
Signa HDxt 22 Female White
Signa HDxt 36 Female White
Signa HDxt 59 Female White
Signa HDxt 63 Male White
Signa HDxt 45 Male White
Signa HDxt 45 Male White
Signa HDxt 51 Male White
Signa HDxt 51 Male White
Signa HDxt 51 Female White
Signa HDxt 49 Male White
Signa HDxt 49 Male White
Signa HDxt 72 Female White
Signa HDxt 49 Female White
Signa HDxt 49 Female White
Signa HDxt 76 Male White
Signa HDxt 76 Male White
Signa HDxt 57 Male Asian
Signa HDxt 44 Male Asian
Signa HDxt 56 Male White
Signa HDxt 61 Male White
Signa HDxt 37 Male White
Signa HDxt 37 Male White
Signa HDxt 55 Male White
Signa HDxt 53 Male White
Signa HDxt 73 Male Unknown
Signa HDxt 38 Male Unknown
Signa HDxt 30 Male White
Signa HDxt 45 Male White
Signa HDxt 51 Male White
Signa HDxt 51 Male White
Signa HDxt 67 Male White
Signa HDxt 67 Male White
Signa HDxt 67 Male White
Signa HDxt 49 Male White
Signa HDxt 66 Male White
Signa HDxt 29 Male White
Signa HDxt 77 Male White
Signa HDxt 77 Male White
Signa HDxt 45 Male White
Signa HDxt 58 Male White
Signa HDxt 56 Female White
Signa HDxt 65 Female White
Signa HDxt 64 Female Unknown
Signa HDxt 64 Female Unknown
Signa HDxt 69 Male White
Signa HDxt 57 Female White
Signa HDxt 57 Female White
Signa HDxt 40 Male White
Signa HDxt 70 Male White
Signa HDxt 70 Male White
Signa HDxt 47 Female White
Signa HDxt 81 Male White
Signa HDxt 81 Male White
Ethnicity Primary Diagnosis
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Not Hispanic or Latino Glioblastoma
Hispanic or Latino Glioblastoma
Unknown or not reported Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Anaplastic Astrocytoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Hispanic or Latino Glioblastoma
Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Not Hispanic or Latino Astrocytoma, IDH-Mutant, Grade 4
Not Hispanic or Latino Astrocytoma, IDH-Mutant, Grade 4
Not Hispanic or Latino Astrocytoma, IDH-Mutant, Grade 4
Not Hispanic or Latino Astrocytoma, IDH-Mutant, Grade 5
Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Unknown or not reported Astrocytoma, IDH-Mutant, Grade 4
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Oligoastrocytoma
Unknown or not reported Oligoastrocytoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Not Hispanic or Latino Glioblastoma
Not Hispanic or Latino Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Unknown or not reported Glioblastoma
Days from Acquisition to Date of initial surgery, treat Days from Acquisition toWHO 2021 Diagnosis
-25
-29
-25 Glioblastoma
-42 -10 Glioblastoma
-95 -63 Glioblastoma
-26 Glioblastoma
-28
-27
-11
-20
-24 Glioblastoma
-40 Glioblastoma
-37
-35
-19
-14
Unknown
-35
-33
-49
-51
Unknown
-26
-36
-42
Unknown -36
Unknown
-19
-33
-43
-12
-28
-42
-21
Unknown
Unknown
-60
0
-78
-59
-82
-36
-20
-21
-33
-59
-37
-42
Unknown
-43
-88
Unknown
Unknown
-28
Unknown
-26
-28
Unknown
Unknown
Unknown
Unknown
-42
-62
Unknown
Unknown
Unknown
Unknown
Unknown
-42
-26
-33
-52 -17 Glioblastoma
-35 Glioblastoma
-17 Glioblastoma
-90 Glioblastoma
Unknown Glioblastoma
-25 Glioblastoma
-33 Glioblastoma
-91 Glioblastoma
-21 Gliobastoma
-49 -20
Unknown
Unknown
-52 -21
-40
Unknown
-26
-27
-24
-22
Unknown
-16
-70 -45
-28
-9
Unknown
-81
Unknown
-21
-22
-21
Unknown
-50
Unknown
-29
-647 -336
-196
-117
-803 -144
-341
-105
-108 Glioblastoma
-208 -176 Glioblastoma
-199 Glioblastoma
-801
-1109
-173
-272
-380 -349
-137
-280
-585
Unknown -290
Unknown -631
-364
-484
-608
-749 -90
-314
-498 -140
-2540
-2657
-258
-355 -89
-1886 -601
-210
-344 -67
-640 -224
-201
-228
-98
-150
-237
-254
-115 Glioblastoma
-172 Glioblastoma
-273 Glioblastoma
-98
-156 -32
-189 -65
Unknown -2249
Unknown -2393
-1609
-344
-391
-413
-1097
-1114 -9
-1141 -36
-224
-348 -83
-477 -219
-303
Unknown
-670 -634
-700 -664
-761 -725
-680 -21 Glioblastoma
-1037 Glioblastoma
-302 Glioblastoma
-357 -140
-157
-360
-788 -131
-841 -37
-887 -83
-1313 -28
-129 -79
-168 -10
-204 -46
-1914 -1647
-437
-558 -104
-188
-232 -23
-302 -93
-260
Unknown
-126 -95
-374 -52
-358
-15
-91
-810
-468
-643
-365 -30
Unknown
-351
-456
Unknown
Unknown
Unknown
Unknown
-420 -110
-209
-552
-979
Unknown
-188
-92 35
-112
-303 -123
-123
Unknown
-94
-191
-267
Unknown
-163
-161
Unknown
-238
-127
-185
Unknown Unknown
Unknown
-281
-463
-841
-151
-989
-64
-171 -96
-440 -196
-407 -14
-620 -227
-100
-195 -22
-240 -205
-622
-218
-408
Non WHO 2021 DiagnosGrade MGMT IDH 1p19q ATRX
Glioblastoma 4 Methylated Wild type Intact
Glioblastoma 4 Methylated Wild type Intact
4 Methylated Wild type Intact Intact
4 Methylated Wild type Intact Intact
4 Methylated Wild type Intact Intact
4 Methylated Wild type Intact Loss
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4 Methylated Wild type Intact Intact
4 Methylated Wild type
4 Methylated
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 Intact
Glioblastoma 4 Methylated Wild type
Glioblastoma 4 Wild type
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 Wild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 Methylated Mutant Intact Loss
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Loss
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Wild type
Glioblastoma 4 Wild type Intact Intact
Glioblastoma 4 Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 Methylated Mutant Codeleted Loss
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 Methylated Mutant
Glioblastoma 4
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 Wild type
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 Methylated Wild type
Glioblastoma 4 Wild type Intact
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 Wild type Loss
Glioblastoma 4 Methylated Wild type Loss
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Codeleted Loss
Glioblastoma 4 Methylated Wild type Codeleted Loss
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact
4 UnmethylateWild type Codeleted Intact
4 Methylated Mutant Intact
4 UnmethylateWild type Intact Intact
4 UnmethylateWild type Intact Intact
4 Wild type Intact Intact
4 UnmethylateWild type Intact Intact
4 Methylated Wild type Intact Intact
4 Methylated Wild type
4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Loss
Glioblastoma 4 UnmethylateWild type Intact Loss
Glioblastoma 4
Glioblastoma 4 Codeleted
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4 Intact
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 Wild type
Glioblastoma 4
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4 Wild type
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4 Unmethylated
Glioblastoma 4 Methylated Wild type
Glioblastoma 4 Methylated Wild type Intact Loss
Glioblastoma 4 Methylated Wild type Intact
Glioblastoma 4 Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact
Glioblastoma 4 Methylated Wild type Intact
Glioblastoma 4 Methylated Wild type Intact Intact
4 Methylated Wild type Intact Intact
4 Methylated Wild type Intact Intact
4 Methylated Wild type
Astrocytoma 3 Methylated Mutant Intact Loss
Glioblastoma 4 Methylated Wild type Intact
Glioblastoma 4 Methylated Wild type Codeleted Loss
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4
Glioblastoma 4 Wild type
Glioblastoma 4 Wild type
Glioblastoma 4 Methylated Wild type
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4 Methylated Wild type Intact
Glioblastoma 4 Methylated Wild type Intact
Glioblastoma 4 UnmethylateMutant Intact
Glioblastoma 4 UnmethylateMutant Intact
Glioblastoma 4 Mutant
Glioblastoma 4 Mutant
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4 Mutant
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 Wild type
4 Methylated
4 Methylated
4 Methylated
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Mutant Intact Loss
Glioblastoma 4 Mutant Intact Loss
Astrocytoma 2 Intact Loss
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Wild type Codeleted
Glioblastoma 4 Wild type Codeleted
Glioblastoma 4 Wild type Codeleted
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 Methylated
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Methylated Mutant Intact Loss
Glioblastoma 4 Methylated Mutant Intact Loss
Glioblastoma 4 Methylated Mutant Intact Loss
4 Methylated Wild type Intact
4 Wild type Intact Intact
4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 Methylated Wild type
Glioblastoma 4 Methylated Wild type
Glioblastoma 4 Methylated Wild type
Glioblastoma 4 Methylated Wild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4 UnmethylateWild type Intact Intact
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Oligoastrocytoma 3 Intact
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 Methylated Wild type
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4 Methylated Wild type
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4 Wild type
Glioblastoma 4 Mutant
Glioblastoma 4 Mutant
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4
Glioblastoma 4 Unmethylated
Glioblastoma 4 Methylated Intact
Glioblastoma 4 Methylated Intact
Glioblastoma 4 Methylated Intact
Glioblastoma 4 Unmethylated Intact
Glioblastoma 4 Unmethylated Intact
Glioblastoma 4 Wild type
Glioblastoma 4 Wild type
Glioblastoma 4 UnmethylateWild type
Glioblastoma 4 Methylated
Glioblastoma 4 Methylated
Glioblastoma 4
Glioblastoma 4 UnmethylateWild type Intact
Glioblastoma 4 Mutant
Glioblastoma 4 Intact
Glioblastoma 4 Mutant
Glioblastoma 4 Mutant
Days from Acquisition to Date of last follow-up
1156
1176
251
1042
989
491
477
267
283
472
95
622
405
529
497
125
28
731
609
92
487
9
549
5
-20
2322
723
680
1881
264
2222
171
392
516
2122
2072
-42
94
594
435
51
1887
266
529
1812
711
369
893
217
915
733
205
498
Unknown
316
216
622
827
89
412
146
118
142
115
66
35
119
58
330
365
155
151
1094
109
36
Unknown
535
420
600
179
392
274
200
511
-26
30
28
1
627
1371
105
425
3978
334
788
10
256
917
1221
285
175
-1
240
57
919
2189
1948
1839
322
864
71
168
876
517
742
1855
401
411
183
1200
1057
702
996
655
430
310
573
432
Unknown
Unknown
490
373
1695
1598
366
84
322
47
93
66
412
103
433
156
547
490
389
174
116
83
41
-103
530
251
204
182
82
65
38
194
70
209
122
387
623
593
532
501
919
763
83
684
481
190
137
91
939
313
274
238
600
127
6
251
207
137
112
17
437
70
309
246
170
205
111
305
137
647
275
60
Unknown
195
384
190
58
885
2478
2051
242
49
121
540
349
188
917
1162
801
2
297
128
173
685
113
603
545
-25
483
1476
1294
916
1091
253
605
498
1
300
87
56
602
156
329
247
57
Days from Acquisition to Date of death Overall survival
1177 Unknown
1204 Unknown
255 Unknown
1076 1202
1023 Unknown
516 Unknown
511 Unknown
280 Unknown
444 280
502 Unknown
117 Unknown
651 Unknown
522 Unknown
798 542
532 Unknown
149 Unknown
705 Unknown
997 Unknown
636 Unknown
228 Unknown
521 Unknown
71 Unknown
674 Unknown
91 Unknown
83 Unknown
Unknown Unknown
766 Unknown
723 Unknown
2007 539
339 307
Unknown Unknown
855 Unknown
497 Unknown
570 455
Unknown Unknown
Unknown Unknown
685 Unknown
231 Unknown
669 522
472 Unknown
71 Unknown
Unknown 141
316 Unknown
553 Unknown
Unknown Unknown
790 Unknown
388 Unknown
901 Unknown
273 Unknown
1054 Unknown
857 Unknown
289 Unknown
554 Unknown
Unknown Unknown
501 Unknown
312 Unknown
648 Unknown
912 Unknown
152 Unknown
462 Unknown
151 Unknown
189 Unknown
Unknown Unknown
130 Unknown
81 Unknown
44 Unknown
159 Unknown
98 Unknown
462 Unknown
433 Unknown
438 Unknown
347 Unknown
Unknown Unknown
185 Unknown
112 Unknown
214 Unknown
561 559
427 Unknown
633 Unknown
221 Unknown
392 Unknown
281 833
207 Unknown
Unknown Unknown
494 Unknown
42 Unknown
82 Unknown
63 551
648 163
1433 774
126 1032
461 669
369 277
394 572
838 82
147 700
Unknown 127
927 125
1639 Unknown
342 742
275 742
123 Unknown
358 382
130 Unknown
945 883
Unknown 539
Unknown 591
1876 Unknown
399 Unknown
892 745
137 246
172 747
910 531
Unknown 153
Unknown Unknown
Unknown 336
419 574
497 Unknown
Unknown 849
1220 425
1077 943
715 357
Unknown 1097
Unknown 945
441 374
321 566
594 Unknown
453 514
Unknown 338
Unknown 676
541 934
424 222
Unknown 494
Unknown 167
382 231
97 Unknown
368 150
Unknown 150
Unknown 110
Unknown 186
493 186
153 504
489 459
174 471
576 364
519 Unknown
418 202
630 202
572 258
539 Unknown
Unknown 460
Unknown Unknown
561 242
289 441
242 287
220 287
93 Unknown
76 Unknown
49 Unknown
230 Unknown
106 Unknown
220 Unknown
Unknown Unknown
411 Unknown
719 Unknown
689 Unknown
628 Unknown
522 Unknown
956 Unknown
Unknown Unknown
184 534
704 Unknown
501 Unknown
385 Unknown
332 64
286 Unknown
955 Unknown
430 108
391 Unknown
355 Unknown
623 Unknown
Unknown Unknown
Unknown Unknown
289 Unknown
245 90
175 Unknown
Unknown Unknown
40 672
897 Unknown
Unknown Unknown
318 Unknown
274 1455
198 215
222 Unknown
134 477
Unknown Unknown
173 439
661 Unknown
289 422
129 Unknown
31 Unknown
Unknown Unknown
Unknown Unknown
241 Unknown
77 Unknown
924 Unknown
2529 Unknown
2102 Unknown
288 Unknown
95 Unknown
Unknown 847
590 Unknown
399 Unknown
Unknown Unknown
927 Unknown
1169 Unknown
846 Unknown
176 Unknown
388 945
219 Unknown
182 1660
759 Unknown
Unknown Unknown
625 364
567 Unknown
Unknown Unknown
531 Unknown
1493 Unknown
1311 296
933 140
1509 408
671 145
625 Unknown
518 Unknown
37 Unknown
349 Unknown
136 Unknown
137 Unknown
652 Unknown
199 Unknown
368 Unknown
Unknown 974
Unknown Unknown
Progression Free survival Surgery Number of suSurgery extend Radiation
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
619 Yes 2 GTR No
Unknown Yes 2 GTR Yes
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
244 Yes 1 GTR No
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
Unknown Yes 1 STR No
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
Unknown No 0 Biopsy No
Unknown No 0 Biopsy Yes
Unknown Yes 1 GTR No
Unknown No 0 Biopsy No
Unknown Yes 1 GTR No
Unknown Yes 1 STR No
Unknown No 0 Biopsy No
Unknown Yes 1 GTR No
Unknown Yes 1 STR No
Unknown Yes 1 STR No
Unknown Yes 3 STR No
Unknown No 0 GTR No
Unknown Yes 1 GTR No
28 Yes 1 STR No
210 Yes 1 STR No
Unknown Yes 1 STR No
Unknown Yes 1 STR No
Unknown Yes 1 STR No
201 Yes 1 STR No
Unknown No 0 Biopsy No
Unknown No 0 Biopsy Yes
Unknown Yes 1 GTR No
Unknown Yes 1 STR No
20 Yes 1 STR Yes
Unknown Yes 1 STR Yes
Unknown Yes 1 STR Yes
24 Yes 1 STR No
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
Unknown Yes 1 STR No
Unknown Yes 1 GTR No
Unknown No 0 Biopsy Yes
Unknown Yes 1 STR No
Unknown Yes 1 GTR Yes
Unknown No 0 Biopsy Yes
Unknown No 0 Biopsy No
Unknown Yes 1 GTR No
Unknown No 0 Biopsy No
Unknown Yes 1 STR No
Unknown Yes 1 STR No
Unknown No 0 Biopsy No
Unknown No 0 Biopsy Yes
Unknown No 0 Biopsy No
Unknown No 0 Biopsy No
Unknown Yes 1 GTR No
Unknown Yes 1 STR No
Unknown No 0 Biopsy No
Unknown No 0 Biopsy Yes
Unknown No 0 Biopsy Yes
Unknown No 0 Biopsy No
Unknown No 0 Biopsy Yes
Unknown Yes 1 STR No
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
Unknown Yes 2 GTR No
Unknown Yes 1 GTR No
Unknown Yes 1 STR No
Unknown Yes 1 STR Yes
Unknown No 0 Biopsy No
37 Yes 1 GTR No
Unknown Yes 1 STR No
Unknown Yes 1 STR Yes
Unknown Yes 1 GTR No
Unknown Yes 2 STR No
392 No 0 Biopsy No
Unknown No 0 Biopsy Yes
Unknown Yes 2 STR No
Unknown Yes 1 STR No
Unknown No 0 Biopsy No
Unknown Yes 1 GTR No
166 Yes 1 STR No
0 Yes 1 STR No
620 Yes 1 STR No
747 No 0 Biopsy Yes
369 Yes 1 GTR No
Yes 2 GTR Yes
395 Yes 1 STR No
-8 Yes 1 GTR No
300 No 0 Biopsy Yes
36 Yes 1 STR No
42 No 0 Biopsy No
Unknown Yes 1 GTR No
335 Yes 1 GTR No
335 Yes 1 STR No
1438 No 0 Biopsy No
213 Yes 1 GTR No
1077 No 0 Biopsy No
256 Yes 1 STR No
391 Yes 2 GTR Yes
395 Yes 1 GTR Yes
Unknown Yes 1 GTR Yes
Unknown Yes 2 GTR Yes
447 Yes 1 GTR Yes
156 Yes 1 GTR Yes
15 Yes 1 GTR Yes
332 Yes 2 GTR Yes
27 Yes 1 GTR Yes
Unknown Yes 1 STR Yes
133 Yes 1 GTR Yes
516 Yes 1 STR Yes
Unknown Yes 1 STR Yes
59 Yes 2 STR Yes
37 Yes 1 GTR Yes
760 Yes 1 GTR Yes
266 Yes 1 STR Yes
475 Yes 2 GTR Yes
816 Yes 2 GTR Yes
252 Yes 1 GTR Yes
361 Yes 1 GTR Yes
Unknown Yes 1 GTR Yes
13 Yes 2 STR Yes
 26 Yes 1 STR Yes
441 Yes 2 STR Yes
133 Yes 1 STR Yes
70 Yes 1 STR Yes
32 Yes 1 STR Yes
167 Yes 2 STR Yes
188 Yes 2 GTR Yes
62 Yes 1 GTR Yes
20 Yes 2 GTR Yes
20 Yes 2 GTR Yes
35 Yes 1 GTR Yes
27 Yes 1 GTR Yes
27 Yes 1 GTR No
328 Yes 1 GTR Yes
215 Yes 1 GTR Yes
216 Yes 1 GTR Yes
168 Yes 1 GTR Yes
Unknown Yes 1 GTR Yes
90 Yes 1 GTR Yes
90 Yes 1 GTR Yes
114 Yes 2 GTR Yes
25 Yes 2 GTR Yes
164 Yes 2 GTR Yes
Unknown Yes 2 GTR Yes
144 Yes 1 STR Yes
268 Yes 1 STR Yes
276 Yes 1 STR Yes
276 Yes 1 STR Yes
Unknown Yes 1 STR Yes
Unknown Yes 2 STR Yes
Unknown Yes 2 STR Yes
Unknown Yes 1 STR Yes
Unknown Yes 2 STR Yes
Unknown Yes 2 GTR Yes
Unknown Yes 1 STR Yes
Unknown No 0 Biopsy Yes
Unknown Yes 2 STR Yes
Unknown Yes 2 STR Yes
Unknown Yes 2 STR Yes
Unknown Yes 2 GTR Yes
Unknown Yes 1 GTR Yes
Unknown Yes 1 GTR Yes
402 Yes 2 GTR Yes
Unknown Yes 1 STR Yes
Unknown Yes 1 STR Yes
Unknown Yes 2 GTR Yes
54 Yes 3 GTR Yes
Unknown Yes 3 GTR Yes
Unknown Yes 2 GTR Yes
26 Yes 2 STR Yes
Unknown Yes 3 STR Yes
Unknown Yes 3 STR Yes
Unknown Yes 2 GTR Yes
Unknown Yes 1 GTR Yes
Unknown Yes 2 GTR Yes
Unknown Yes 1 GTR No
90 Yes 2 GTR No
Unknown Yes 2 GTR Yes
Unknown Yes 1 STR Yes
376 No 0 Biopsy Yes
Unknown Yes 2 STR Yes
Unknown Yes 2 GTR Yes
Unknown Yes 1 STR Yes
Unknown Yes 1 STR No
215 Yes 1 STR Yes
Unknown Yes 1 GTR Yes
145 Yes 1 STR Yes
Unknown Yes 1 STR Yes
207 Yes 3 GTR Yes
Unknown Yes 1 GTR No
299 Yes 1 GTR Yes
Unknown Yes 1 GTR Yes
Unknown No 0 Biopsy No
Unknown Yes 1 GTR No
Unknown Yes 1 GTR No
Unknown No 0 Biopsy Yes
Unknown Yes 2 STR Yes
Unknown Yes 1 GTR Yes
Unknown Yes 1 STR Yes
Unknown Yes 1 STR Yes
Unknown Yes 1 STR No
Unknown Yes 1 STR Yes
162 Yes 2 STR No
Unknown Yes 1 GTR Yes
Unknown Yes 2 GTR Yes
Unknown Yes 1 STR Yes
Unknown Yes 1 GTR No
Unknown Yes 1 STR Yes
Unknown Yes 1 GTR Yes
Unknown No 0 Biopsy Yes
410 No 1 GTR No
Unknown Yes 1 GTR Yes
1620 Yes 1 STR Yes
Unknown Yes 1 STR No
Unknown Yes 1 STR Yes
221 Yes 1 GTR Yes
Unknown Yes 1 GTR Yes
Unknown Yes 2 STR Yes
Unknown Yes 1 GTR No
Unknown Yes 1 GTR Yes
93 Yes 1 GTR Yes
116 Yes 1 GTR Yes
50 Yes 1 GTR Yes
105 Yes 1 GTR Yes
Unknown Yes 1 GTR No
Unknown Yes 2 GTR Yes
Unknown Yes 3 GTR Yes
Unknown Yes 3 STR Yes
Unknown Yes 3 STR Yes
Unknown Yes 1 GTR No
Unknown Yes 2 GTR Yes
Unknown Yes 2 GTR Yes
Unknown Yes 1 STR Yes
714 Yes 1 GTR Yes
Unknown Yes 1 GTR Yes
Number of radiation couDays from Acquistion to Date of first radiation
Unknown
Unknown
Unknown
Unknown
1 -41
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
2 -62
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
1 -43
Unknown
Unknown
1 -60
1 -46
1 -48
Unknown
 Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
1 -77
Unknown
1 -38
1 -47
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
1 -58
Unknown
Unknown
Unknown
Unknown
Unknown
1 -46
1 -45
Unknown
1 -54
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
1 -56
Unknown
Unknown
Unknown
1 -65
Unknown
Unknown
Unknown
1 -66
Unknown
Unknown
 Unknown
Unknown
Unknown
Unknown
Unknown
1 -75
Unknown
1 -34
Unknown
Unknown
1 Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
1 -591
2 -140
1 -73
2 -768
1 -294
1 -71
1 -75
1 -154
1 -155
2 -766
1 -1086
1 -131
1 -238
1 3697
1 -95
1 -238
1 -540
1 Unknown
1 Unknown
1 -336
1 -456
1 -573
1 -714
1 -251
1 -435
2 Unknown
2 Unknown
1 -216
1 -313
1 -1800
1 -163
1 -314
1 Unknown
1 -162
1 -189
Unknown
1 -73
1 -190
1 -225
1 -70
1 -127
1 -228
1 -70
1 -128
1 -161
1 -2215
1 -2359
1 -850
1 -312
1 -359
1 -381
1 Unknown
1 Unknown
1 Unknown
1 -195
1 -319
1 -440
1 -268
1 Unknown
1 -594
1 -624
1 -685
1 -645
1 -993
1 -255
1 -327
1 -144
1 -347
1 -746
1 -799
2 -845
1 -1227
1 -91
1 -130
1 -166
1 -1874
1 -390
1 -511
Unknown
Unknown
1 -64
1 -148
1 Unknown
1 -67
1 Unknown
1 -328
Unknown
1 -70
1 -777
1 -440
1 -596
1 -288
Unknown
1 -321
1 Unknown
Unknown
Unknown
Unknown
1 -89
1 -385
1 -174
1 Unknown
1 Unknown
Unknown
1 -162
Unknown
1 -77
1 -268
1 -100
 Unknown
1 -66
1 -152
1 -395

1 -132
1 Unknown
Unknown
1 -225
1 -91
1 -149
1 -486
Unknown
1 Unknown
1 Unknown
1 Unknown
1 -127
1 -965
Unknown
1 -60
1 -414
1 -346
1 -559
Unknown
1 -159
1 -204
1 Unknown
1 -189
1 -379
Days from Acquistion to Date of last radiation pri1st Chemo type Days from Acquisition t
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
0 Temodar -41
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
-16 Temodar -62
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
-22 Temodar -43
Unknown Unknown
Unknown Unknown
-20 Temodar -60
-3 Temodar -46
-6 Temodar -48
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
-28 Temodar -77
Unknown Unknown
-18 Temodar -38
-32 Temodar -47
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
-37 Temodar -58
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
-26 Temodar -46
-24 Temodar -45
Unknown Unknown
-33 Temodar -61
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
-17 Temodar -56
Unknown Unknown
Unknown Unknown
Unknown Unknown
-29 Temodar -65
Unknown Unknown
Unknown Unknown
Unknown Unknown
-24 Temodar -66
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
-35 Temodar -75
Unknown Unknown
8 Temodar -34
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Unknown
Unknown Temodar -23
Unknown Unknown
Unknown Unknown
-914 Temodar -591
-97 Temodar -132
-30 Temodar -73
-18 Temodar -768
-252 Temodar -294
-28 Temodar -71
-28 Temodar -75
-113 Temodar -154
-113 Temodar -155
-94 Temodar -766
-1042 Temodar -1086
-83 Temodar -131
-197 Temodar -238
-279 Temodar -321
-54 Temodar -95
-197 Temodar -238
-499 Temodar -540
Unknown Temodar Unknown
Unknown Temodar Unknown
-286 Temodar -336
-406 Temodar -456
-531 Temodar -573
-672 Temodar -714
Unknown Temodar -251
Unknown Temodar -435
-34 Temodar Unknown
-151 Temodar Unknown
-173 Temodar -216
-270 Temodar -313
Unknown Temodar -1800
-120 Temodar -163
-271 Temodar -314
Unknown Temodar Unknown
-120 Temodar -162
-147 Temodar -189
Unknown
-30 Temodar -73
-148 Temodar -190
-186 Temodar -225
-28 Temodar -70
-85 Temodar -127
-186 Temodar -228
-28 Temodar -70
-86 Temodar -128
-119 Temodar -161
-2157 Temodar Unknown
-2301 Temodar Unknown
-813 Temodar -850
-273 Temodar -312
-320 Temodar -359
-342 Temodar -381
Unknown Temodar Unknown
Unknown Temodar Unknown
Unknown Temodar Unknown
-162 Temodar -195
-286 Temodar -319
-398 Temodar -440
-226 Temodar -268
-875 Temodar Unknown
-550 Temodar -594
-580 Temodar -624
-641 Temodar -685
-603 Temodar -645
-950 Temodar -993
-211 Temodar -255
-280 Temodar -327
-72 Temodar -144
-275 Temodar -347
-705 Temodar -746
-758 Temodar -799
-27 Temodar -845
-1185 Temodar -1227
-35 Temodar -91
-74 Temodar -130
-110 Temodar -166
-1835 Temodar -1874
-348 Temodar -390
-469 Temodar -511
Unknown CCNU -162
Unknown CCNU -206
-46 CCNU -276
-98 Temodar -148
Unknown Temodar Unknown
-25 Temodar -67
Unknown
-286 Temodar -328
Unknown
-28 Temodar -70
-732 Temodar -679
-398 Temodar -440
-575 Temodar -606
-246 Temodar -288
Unknown
-279 Temodar -321
Unknown Temodar Unknown
Unknown
Unknown
Unknown
-62 Temodar -89
-343 Temodar -385
-117 Temodar -116
Unknown Temodar Unknown
Unknown Temodar Unknown
Unknown
-120 Temodar -162
Unknown
-34 Temodar -77
-225 Temodar -268
-57 Temodar -100
Unknown
-24 Temodar -66
-108 Temodar -152
-330 Temodar -395
Unknown
-90 Temodar -132
-83 Temodar Unknown
Unknown
-170 Temodar -125
-21 Temodar -91
-79 Temodar -149
Unknown Temodar -486
Unknown Unknown
Unknown Temodar Unknown
Unknown Temodar Unknown
Unknown Temodar Unknown
-85 Temodar -127
-923 Temodar -965
Unknown Unknown
-14 Temodar -60
-375 Temodar -414
-304 Temodar -346
-517 Temodar -559
Unknown Unknown
-120 Temodar -159
-162 Temodar -204
Unknown Temodar Unknown
-148 Temodar -189
-338 Temodar -379
Avastin® Days from Acquisition to DateOther treatme
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
Yes -60 No
No Unknown Yes
No Unknown Yes
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown Yes
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown Yes
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
Yes -17 No
No Unknown No
Yes -28 No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown Yes
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown Yes
No Unknown No
No Unknown No
No Unknown No
No Unknown Yes
No Unknown No
No Unknown No
No Unknown No
No Unknown No
Yes Unknown No
No Unknown No
No Unknown Yes
No Unknown No
Yes Unknown No
No Unknown No
No Unknown No
No Unknown Yes
Yes Unknown No
Yes Unknown No
Yes -25 No
Yes -98 Yes
No Unknown Yes
No Unknown Yes
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
Yes 21 No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown Yes
No Unknown Yes
No Unknown Yes
Yes -61 Yes
Yes -78 Yes
Yes -105 Yes
No Unknown No
No Unknown Yes
No Unknown Yes
No Unknown No
No Unknown Yes
No Unknown Yes
No Unknown Yes
No Unknown Yes
No Unknown Yes
No Unknown Yes
No Unknown Yes
Yes 0 No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown Yes
No Unknown Yes
No Unknown No
No Unknown No
No Unknown No
No Unknown No
Yes 0 No
Yes -136 No
Yes -13 No
Yes -25 No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
Yes 0 Yes
Yes -27 Yes
Yes 0 Yes
No Unknown Yes
No Unknown No
No Unknown No
No Unknown Yes
N Unknown No
Yes 127 No
Yes 316 No
No Unknown No
No Unknown Yes
No Unknown No
No Unknown No
No Unknown No
No Unknown Yes
Yes 61 Yes
No Unknown No
No Unknown No
No Unknown Yes
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown Yes
No Unknown No
No Unknown No
Yes Unknown Yes
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
No Unknown No
Yes -61 Yes
No Unknown No
Yes 0 No
No Unknown No
No Unknown No
No Unknown Yes
No Unknown No
No Unknown No
No Unknown No
Days from Acquisition to Other treatment dates
Unknown

Unknown
Unknown
Unknown

Unknown

Unknown
Unknown

Unknown

Unknown

Unknown

Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown

Unknown
Unknown

Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown

Unknown
Unknown
Unknown
Unknown

Unknown

Unknown

Unknown

Unknown
Unknown

Unknown

Unknown

Unknown